History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts

IF 3.9 2区 医学 Q1 CLINICAL NEUROLOGY European Journal of Neurology Pub Date : 2025-03-20 DOI:10.1111/ene.70090
Angus McNamara, Irina Baetu, Lyndsey Collins-Praino
{"title":"History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts","authors":"Angus McNamara,&nbsp;Irina Baetu,&nbsp;Lyndsey Collins-Praino","doi":"10.1111/ene.70090","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>A history of traumatic brain injury (TBI) is associated with an increased risk of developing neurodegenerative disorders, including Parkinson's Disease (PD). However, TBI's influences on disease progression remain underassessed. This study explored whether a history of TBI influences the progression of pathological and clinical outcomes up to 5 years of follow-up in individuals with early PD.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Longitudinal data were extracted from the Parkinson's Progression Markers Initiative (PPMI) and the PostCEPT observational study. Participants in PostCEPT had complete head injury data, while PPMI participants were eligible if they completed the head injury section of the PD Risk Factor Questionnaire (<i>n</i> = 208). Principal component analysis was used to derive composite scores of cognitive ability and mood dysfunction, with motor outcomes calculated using the Movement Disorders Society Unified Parkinson's Disease Rating Scale. Progression of clinical and pathological outcomes up to 5 years and 4 years following study entry were compared, including subset analyses in PPMI examining injury severity.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Individuals with a history of TBI in the PPMI dataset exhibited a younger age of onset; however, a history of TBI did not affect progression rates of any assessed variables across both cohorts. Exploratory analysis determined that injury severity significantly predicted striatal dopamine transporter binding but accounted for only a small portion of outcome variance.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>While the history of TBI was associated with earlier PD onset, it did not correspond to a differential disease course. However, given differences in TBI characterisation between cohorts, additional research must be conducted to validate these findings.</p>\n </section>\n </div>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":"32 3","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11926254/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/ene.70090","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

A history of traumatic brain injury (TBI) is associated with an increased risk of developing neurodegenerative disorders, including Parkinson's Disease (PD). However, TBI's influences on disease progression remain underassessed. This study explored whether a history of TBI influences the progression of pathological and clinical outcomes up to 5 years of follow-up in individuals with early PD.

Methods

Longitudinal data were extracted from the Parkinson's Progression Markers Initiative (PPMI) and the PostCEPT observational study. Participants in PostCEPT had complete head injury data, while PPMI participants were eligible if they completed the head injury section of the PD Risk Factor Questionnaire (n = 208). Principal component analysis was used to derive composite scores of cognitive ability and mood dysfunction, with motor outcomes calculated using the Movement Disorders Society Unified Parkinson's Disease Rating Scale. Progression of clinical and pathological outcomes up to 5 years and 4 years following study entry were compared, including subset analyses in PPMI examining injury severity.

Results

Individuals with a history of TBI in the PPMI dataset exhibited a younger age of onset; however, a history of TBI did not affect progression rates of any assessed variables across both cohorts. Exploratory analysis determined that injury severity significantly predicted striatal dopamine transporter binding but accounted for only a small portion of outcome variance.

Conclusion

While the history of TBI was associated with earlier PD onset, it did not correspond to a differential disease course. However, given differences in TBI characterisation between cohorts, additional research must be conducted to validate these findings.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
脑外伤史不会影响两个早期帕金森病队列中临床或病理结果的进展率。
背景:创伤性脑损伤(TBI)病史与发生神经退行性疾病(包括帕金森病(PD))的风险增加有关。然而,TBI对疾病进展的影响仍然被低估。本研究探讨了创伤性脑损伤史是否会影响早期PD患者5年随访期间的病理和临床结果进展。方法:从帕金森进展标志物计划(PPMI)和cept后观察研究中提取纵向数据。后cept的参与者有完整的头部损伤数据,而PPMI的参与者如果完成了PD危险因素问卷的头部损伤部分(n = 208),则符合条件。采用主成分分析得出认知能力和情绪功能障碍的综合评分,并使用运动障碍协会统一帕金森病评定量表计算运动结果。比较研究开始后5年和4年的临床和病理结果进展,包括PPMI检查损伤严重程度的亚群分析。结果:PPMI数据集中有TBI病史的个体表现出更年轻的发病年龄;然而,在两个队列中,TBI病史并不影响任何评估变量的进展率。探索性分析确定,损伤严重程度显著预测纹状体多巴胺转运体结合,但仅占结果方差的一小部分。结论:虽然TBI病史与早期PD发病有关,但它并不对应于不同的疾病病程。然而,考虑到各组间TBI特征的差异,必须进行额外的研究来验证这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Neurology
European Journal of Neurology 医学-临床神经学
CiteScore
9.70
自引率
2.00%
发文量
418
审稿时长
1 months
期刊介绍: The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).
期刊最新文献
Early Detection of Central Nervous System Involvement in ATTRv Using Multimodal MRI and Cognitive Assessments Muscle MRI Contributes to the Differential Diagnosis Between Distal Myopathies and Distal Hereditary Motor Neuropathies Objective Assessment of Facial Expressions in Parkinson's Disease During Deep Brain Stimulation ON and OFF States: A Pilot Study Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy” Letter to the Editor: Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP-Related Therapies in Moyamoya Angiopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1